{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:17:05Z","timestamp":1791994625325,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["KFJ-BRP-008"],"award-info":[{"award-number":["KFJ-BRP-008"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22177110"],"award-info":[{"award-number":["22177110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21861142007"],"award-info":[{"award-number":["21861142007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.imlet.2022.03.003","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T11:04:34Z","timestamp":1646996674000},"page":"28-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["A small molecule inhibitor of caspase-1 inhibits NLRP3 inflammasome activation and pyroptosis to alleviate gouty inflammation"],"prefix":"10.1016","volume":"244","author":[{"given":"Dong-yi","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-ze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ke","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-ying","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2022.03.003_bib0001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature18590","article-title":"Pore-forming activity and structural autoinhibition of the gasdermin family","volume":"535","author":"Ding","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2022.03.003_bib0002","article-title":"NLRP3 Inflammasome and inflammatory diseases","volume":"2020","author":"Wang","year":"2020","journal-title":"Oxid. Med. Cell Longev"},{"key":"10.1016\/j.imlet.2022.03.003_bib0003","doi-asserted-by":"crossref","first-page":"eaah4066","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imlet.2022.03.003_bib0004","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.imlet.2022.03.003_bib0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00281-015-0494-4","article-title":"Caspase-1: an integral regulator of innate immunity","volume":"37","author":"Winkler","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.imlet.2022.03.003_bib0006","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/356768a0","article-title":"A novel heterodimeric cysteine protease is required for interleukin-1\u03b2 processing in monocytes","volume":"356","author":"Thornberry","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2022.03.003_bib0007","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2022.03.003_bib0008","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/jpet.106.111344","volume":"321","author":"Wannamaker","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.imlet.2022.03.003_bib0009","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1063-4584(03)00153-5","article-title":"Pralnacasan, an inhibitor of interleukin-1\u03b2 converting enzyme, reduces joint damage in two murine models of osteoarthritis","volume":"11","author":"Rudolphi","year":"2003","journal-title":"Osteoar. Cartil"},{"key":"10.1016\/j.imlet.2022.03.003_bib0010","first-page":"39","article-title":"The role of the NLRP3 inflammasome in gout","volume":"4","author":"Kingsbury","year":"2011","journal-title":"J. Inflamm. Res"},{"key":"10.1016\/j.imlet.2022.03.003_bib0011","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/art.22938","article-title":"The role of interleukin-1 and the inflammasome in gout: implications for therapy","volume":"56","author":"Pope","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2022.03.003_bib0012","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11926-001-0049-7","article-title":"Pathogenesis of crystal-induced inflammation","volume":"3","author":"Landis","year":"2001","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.imlet.2022.03.003_bib0013","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1172\/JCI28075","article-title":"MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals","volume":"116","author":"Chen","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2022.03.003_bib0014","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","article-title":"Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1\u03b2 production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis","volume":"62","author":"Joosten","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2022.03.003_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2022.03.003_bib0016","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","article-title":"The gasdermins, a protein family executing cell death and inflammation","volume":"20","author":"Broz","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2022.03.003_bib0017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.cdd.4402034","article-title":"Caspase inhibitors: viral, cellular and chemical","volume":"14","author":"Callus","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.imlet.2022.03.003_bib0018","first-page":"568","article-title":"The potential for caspases in drug discovery","volume":"13","author":"MacKenzie","year":"2010","journal-title":"Curr. Opin. Drug Discov. Devel"},{"key":"10.1016\/j.imlet.2022.03.003_bib0019","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/cbdd.12572","article-title":"Lazaroids U83836E and U74389G are potent, time-dependent inhibitors of caspase-1","volume":"86","author":"Kawarski","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.imlet.2022.03.003_bib0020","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1111\/bph.15076","article-title":"Structure-based discovery of CZL80, a caspase-1 inhibitor with therapeutic potential for febrile seizures and later enhanced epileptogenic susceptibility","volume":"177","author":"Tang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.imlet.2022.03.003_bib0021","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.imlet.2022.03.003_bib0022","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","article-title":"Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome","volume":"285","author":"Juliana","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2022.03.003_bib0023","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.1701495","article-title":"Curcumin suppresses IL-1\u03b2 secretion and prevents inflammation through inhibition of the NLRP3 inflammasome","volume":"200","author":"Yin","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2022.03.003_bib0024","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s10753-015-0254-6","article-title":"Effects of administration of amlodipine and lacidipine on inflammation-induced bone loss in the ovariectomized rat","volume":"39","author":"Karakus","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.imlet.2022.03.003_bib0025","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/ijms15011402","article-title":"Phenoxybenzamine is neuroprotective in a rat model of severe traumatic brain injury","volume":"15","author":"Rau","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2022.03.003_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104348","article-title":"Coptisine from Coptis chinensis blocks NLRP3 inflammasome activation by inhibiting caspase-1","volume":"147","author":"Wu","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.imlet.2022.03.003_bib0027","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1016\/j.bmcl.2010.07.004","article-title":"Succinic acid amides as P2-P3 replacements for inhibitors of interleukin-1\u03b2 converting enzyme (ICE or caspase 1)","volume":"20","author":"Galatsis","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.imlet.2022.03.003_bib0028","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/370270a0","article-title":"Structure and mechanism of interleukin-1\u03b2 converting enzyme","volume":"370","author":"Wilson","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2022.03.003_bib0029","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13543776.2017.1378426","article-title":"Caspase inhibitors: a review of recently patented compounds (2013-2015)","volume":"28","author":"Lee","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.imlet.2022.03.003_bib0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","article-title":"Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity","volume":"49","author":"Py","year":"2013","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.imlet.2022.03.003_bib0031","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/febs.15118","article-title":"Control of the inflammasome by the ubiquitin system","volume":"287","author":"Lopez-Castejon","year":"2020","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.imlet.2022.03.003_bib0032","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2022.03.003_bib0033","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.immuni.2020.06.007","article-title":"Caspase-1 engages full-length gasdermin D through two distinct interfaces that mediate caspase recruitment and substrate cleavage","volume":"53","author":"Liu","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2022.03.003_bib34","first-page":"1668","volume":"120","author":"Pulvino","year":"2012","journal-title":"Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A.Blood"},{"key":"10.1016\/j.imlet.2022.03.003_bib35","first-page":"3372","volume":"104","author":"Miggin","year":"2007","journal-title":"et al. NF-\u03baB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1. Proc Natl Acad Sci USA"},{"key":"10.1016\/j.imlet.2022.03.003_bib36","first-page":"35874","volume":"286","author":"Kersse","year":"2011","journal-title":"Interaction patches of procaspase-1 caspase recruitment domains (CARDs) are differently involved in procaspase-1 activation and receptor-interacting protein 2 (RIP2)-dependent nuclear factor \u03baB signaling. J Biol Chem"},{"issue":"37","key":"10.1016\/j.imlet.2022.03.003_bib37","first-page":"1839","volume":"71","author":"Schlesinger","year":"2012","journal-title":"et al. Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann Rheum Dis"},{"issue":"38","key":"10.1016\/j.imlet.2022.03.003_bib38","first-page":"1920","volume":"257","author":"Roberts","year":"1987","journal-title":"Colchicine in acute gout. Reassessment of risks and benefits. JAMA"},{"issue":"39","key":"10.1016\/j.imlet.2022.03.003_bib39","first-page":"1465","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Mechanism of action of colchicine in the treatment of gout. Clin Ther"},{"issue":"1","key":"10.1016\/j.imlet.2022.03.003_bib40","first-page":"203","volume":"233","author":"Shi","year":"2010","journal-title":"Monosodium urate crystals in inflammation and immunity. Immunol Rev"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247822000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247822000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:46:49Z","timestamp":1777495609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247822000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":40,"alternative-id":["S0165247822000360"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2022.03.003","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A small molecule inhibitor of caspase-1 inhibits NLRP3 inflammasome activation and pyroptosis to alleviate gouty inflammation","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2022.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}